Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aceragen, Inc (ACGN)  
$0.38 0.00 (0.00%) as of 4:30 Mon 8/21


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 8,423,000
Market Cap: 3.20(M)
Last Volume: 1,933,173 Avg Vol: 663,431
52 Week Range: $0.38 - $1.85
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Idera Pharmaceuticals is a biopharmaceutical company focused on the clinical development, and the commercialization, of drug candidates for rare disease indications characterized by patient populations with unmet medical needs. Co.'s focus is to identify and acquire rights to development and commercial stage rare disease programs through new business development opportunities, including additional alternatives. Co. is evaluating intratumoral tilsotolimod in combination with nivolumab, an anti-Progressive Disease 1 antibody marketed as Opdivo® by Bristol Myers Squibb Company, and ipilimumab for the treatment of multiple solid tumors in a multicohort trial.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 26,965 26,965
Total Buy Value $0 $0 $38,290 $38,290
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 226,310 273,476
Total Sell Value $0 $0 $333,274 $420,198
Total People Sold 0 0 4 4
Total Sell Transactions 0 0 8 9
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 583
  Page 2 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Taylor John Clayton Chief Executive Officer   •       •      –    2022-09-28 4 A $0.00 $0 D/D 2,171,214 2,171,214     -
   Jordan Andrew R Chief Strategy Officer   •       –      –    2022-09-28 4 A $0.00 $0 D/D 651,364 651,364     -
   Wooten Ronald J Director   –       •      –    2022-09-28 4 A $0.00 $0 I/I 5 5     -
   Salain Daniel Chief Operating Officer   •       –      –    2022-09-28 4 A $0.00 $0 D/D 2,171,214 2,171,214     -
   Zein Youssef El 10% Owner   –       –       •   2022-09-22 4 OE $0.01 $15,332 I/I 1,533,159 7,266,954     -
   Dougherty Michael R   –       •      –    2022-07-01 4 A $0.44 $21,938 D/D 50,086 283,116     -
   Dougherty Michael R   –       •      –    2022-04-01 4 A $0.54 $22,018 D/D 41,155 233,030     -
   Dougherty Michael R   –       •      –    2022-01-03 4 A $0.59 $21,867 D/D 37,062 191,875     -
   Kirby John J. CHIEF FINANCIAL OFFICER   •       –      –    2021-12-17 4 B $0.62 $6,150 D/D 10,000 37,632 0.01 -30%     
   Dougherty Michael R Director   –       •      –    2021-10-04 4 A $1.03 $21,866 D/D 21,229 154,813     -
   Soland Daniel B CHIEF OPERATING OFFICER   •       –      –    2021-06-18 4 B $1.19 $59,500 D/D 50,000 78,843 0.01 -24%     
   Dougherty Michael R   –       •      –    2021-06-01 4 B $1.19 $101,150 D/D 85,000 133,584 0.01 -17%     
   Zein Youssef El 10% Owner   –       –       •   2021-04-01 4/A OE $0.01 $24,958 I/I 2,495,809 2,304,180     -
   Zein Youssef El 10% Owner   –       –       •   2021-03-26 4 OE $0.01 $24,958 I/I 2,495,809 2,492,342     -
   Lim Bryant David SVP AND GENERAL COUNSEL   •       –      –    2021-03-25 4 S $1.36 $10,378 D/D (7,630) 30,434 26%     
   Kirby John J. CHIEF FINANCIAL OFFICER   •       –      –    2021-03-25 4 S $1.42 $8,876 D/D (6,250) 27,632 26%     
   Tarka Elizabeth Ann CHIEF MEDICAL OFFICER   •       –      –    2021-03-25 4 S $1.35 $6,778 D/D (5,018) 13,237 26%     
   Zein Youssef El 10% Owner   –       –       •   2021-03-18 4 S $1.80 $3,057,027 I/I (1,699,765) 1,608,167 80%     
   Soland Daniel B CHIEF OPERATING OFFICER   •       –      –    2021-03-05 4 B $3.90 $38,950 D/D 10,000 28,843 0.01 -76%     
   Zein Youssef El 10% Owner   –       –       •   2021-01-20 4 OE $0.01 $6,435 I/I 643,525 1,931,893     -
   Tarka Elizabeth Ann Chief Medical Officer   •       –      –    2021-01-12 4 S $4.19 $7,310 D/D (1,745) 18,255 73%     
   Kirby John J. Chief Financial Officer   •       –      –    2021-01-12 4 S $4.22 $7,152 D/D (1,693) 33,882 73%     
   Milano Vincent President & CEO   •       •      –    2021-01-12 4 S $4.20 $13,474 D/D (3,210) 208,611 73%     
   Lim Bryant David SVP and General Counsel   •       –      –    2021-01-12 4 S $4.21 $7,202 D/D (1,711) 38,064 73%     
   Lim Bryant David SVP and General Counsel   •       –      –    2021-01-05 4 S $3.91 $5,722 D/D (1,465) 39,775 74%     
  583 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us